查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1656105

实现弹性医药供应链的技术

Technologies Enabling Resilient Pharmaceutical Supply Chains
出版日期: | 出版商: Frost & Sullivan | 英文 43 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

以人工智慧为基础的技术改变了医药供应链网络

本研究的目的是回顾新兴的变革性技术解决方案，以重新设计医药供应链流程并为模型引入更高的弹性、透明度和回应能力。

研究回答了以下问题：大型製药供应链如今必须面对哪些新挑战？新科技如何提高透明度和弹性？有哪些技术解决方案可以实现医药供应链中主要相关人员之间的连结和沟通？鑑于最近的全球经济衝击，製药公司可以部署哪些新的技术应用策略来使其供应链更快、更有效率？管理人员如何释放与科技公司的供应商协同效应，让製药公司从开发更强大、一体化的医药供应协同效应模式中获益？该领域主要企业的财务资源、技术准备和策略合作将如何影响医药供应链的发展和潜在成功？

目录

战略问题

  • 成长为何变得越来越艰难？
  • The Strategic Imperative 8（TM）
  • 三大策略挑战对实现弹性医药供应链的技术的影响
  • 成长机会推动Growth Pipeline Engine（TM）™
  • 调查方法

成长机会分析

  • 分析范围
  • 介绍
  • 分割

成长要素

  • 成长动力
  • 成长抑制因素

利用科技：医药供应链管理的新时代

  • 从製造商到批发商
  • 从批发商到药局
  • 从药局到患者

医药供应链创新新前景

  • 医药供应链中的关键参与企业

相关人员如何影响医药供应链的效率

  • 资金筹措分析
  • 重要伙伴关係与收购（2021-2024）

确保药品分销的可近性和安全性

  • 製造商到批发商：视角
  • 从批发商到药局：视角
  • 药局到患者：一个视角

医药供应链中的成长机会领域

  • 成长机会1：物联网追踪与监控
  • 成长机会二：区块链带来更高的透明度和可追溯性
  • 成长机会三：资料分析与以人工智慧为基础的决策

后续步骤Next steps

  • 成长机会的好处和影响
  • 后续步骤Next steps
  • 免责声明
简介目录
Product Code: DB13

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model.

The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience? How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders? Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient? How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain? How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Technologies Enabling Resilient Pharmaceutical Supply Chains
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Introduction
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Harnessing Technology: A New Era in Pharmaceutical Supply Chain Management

  • Manufacturers to Wholesalers
  • Wholesalers to Pharmacies
  • Pharmacies to Patients

Emerging Innovation Landscape for the Pharmaceutical Supply Chain

  • Key Pharmaceutical Supply Chain Participants

Impact of Stakeholders on Pharmaceutical Supply Chain Efficiency

  • Funding Analysis
  • Key Partnerships and Acquisitions, 2021-2024

Ensuring Access and Safety in Drug Distribution

  • Manufacturers to Wholesalers-Outlook
  • Wholesalers to Pharmacies-Outlook
  • Pharmacies to Patients-Outlook

Growth Opportunity Universe in the Pharmaceutical Supply Chain

  • Growth Opportunity 1: IoT-enabled Tracking and Monitoring
  • Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability
  • Growth Opportunity 3: Data Analytics and AI-driven Decision-making

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer